| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 45 | 42 | |
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | 49 | 43 | |
| 2007 | Acute intermittent porphyria with peripheral neuropathy: A follow-up study after hematin treatment | Kuo H.-C.; MING-JEN LEE ; Chuang W.-L.; Huang C.-C. | Journal of the Neurological Sciences | 18 | 17 | |
| 2015 | Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial | Buti M.; Flisiak R.; JIA-HORNG KAO ; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. | Journal of Viral Hepatitis | 17 | 17 | |
| 2019 | APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? | Kanda T.; Lau G.K.K.; Wei L.; Moriyama M.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Sarin S.K.; Omata M. | Hepatology International | 31 | 27 | |
| 2012 | APASL consensus statements and management algorithms for hepatitis C virus infection | Omata M.; Kanda T.; Yu M.-L.; Yokosuka O.; Lim S.-G.; Jafri W.; Tateishi R.; Hamid S.S.; Chuang W.-L.; Chutaputti A.; Wei L.; Sollano J.; Sarin S.K.; JIA-HORNG KAO ; McCaughan G.W. | Hepatology International | 143 | 131 | |
| 2016 | APASL consensus statements and recommendation on treatment of hepatitis C | Omata M.; Kanda T.; Wei L.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Lau G.K.K.; Sarin S.K. | Hepatology International | 177 | 162 | |
| 2016 | APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing | Omata M.; Kanda T.; Wei L.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Dokmeci A.K.; Al-Mahtab M.; McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Yokosuka O.; Lau G.K.K.; Sarin S.K. | Hepatology International | 71 | 69 | |
| 2019 | APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation | Kanda T.; Lau G.K.K.; Wei L.; Moriyama M.; Yu M.-L.; Chuang W.-L.; Ibrahim A.; Lesmana C.R.A.; Sollano J.; Kumar M.; Jindal A.; Sharma B.C.; Hamid S.S.; Kadir Dokmeci A.; Mamun-Al-Mahtab, McCaughan G.W.; Wasim J.; Crawford D.H.G.; JIA-HORNG KAO ; Ooka Y.; Yokosuka O.; Sarin S.K.; Omata M. | Hepatology International | 56 | 54 | |
| 2012 | Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update | Liaw Y.-F.; JIA-HORNG KAO ; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU ; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M. | Hepatology International | 816 | 774 | |
| 2017 | The autophagy marker LC3 strongly predicts immediate mortality after surgical resection for hepatocellular carcinoma | Lin C.-W.; Lin C.-C.; PO-HUANG LEE ; Lo G.-H.; Hsieh P.-M.; Koh K.W.; CHIH-YUAN LEE ; Chen Y.-L.; Dai C.-Y.; Huang J.-F.; Chuang W.-L.; Chen Y.-S.; Yu M.-L. | Oncotarget | 10 | 10 | |
| 2018 | Autophagy-related gene LC3 expression in tumor and liver microenvironments significantly predicts recurrence of hepatocellular carcinoma after surgical resection article | Lin C.-W.; Chen Y.-S.; Lin C.-C.; PO-HUANG LEE ; Lo G.-H.; Hsu C.-C.; Hsieh P.-M.; Koh K.W.; Chou T.-C.; Dai C.-Y.; Huang J.-F.; Chuang W.-L.; Chen Y.-L.; Yu M.-L. | Clinical and Translational Gastroenterology | 18 | 16 | |
| 2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
| 2021 | The case for simplifying and using absolute targets for viral hepatitis elimination goals | Razavi H.; Blach S.; Razavi-Shearer D.; Abaalkhail F.; Abbas Z.; Abdallah A.; Abrao Ferreira P.; Abu Raddad L.J.; Adda D.; Agarwal K.; Aghemo A.; Ahmed A.; Al-Busafi S.A.; Al-hamoudi W.; Al-Kaabi S.; Al-Romaihi H.; Aljarallah B.; AlNaamani K.; Alqahtani S.; Alswat K.; Altraif I.; Asselah T.; Bacon B.; Bessone F.; Bizri A.R.; Block T.; Bonino F.; Brandão-Mello C.E.; Brown K.; Bruggmann P.; Brunetto M.R.; Buti M.; Cabezas J.; Calleja J.L.; Castro Batänjer E.; Chan H.L.-Y.; Chang H.; Chen C.-J.; Christensen P.B.; Chuang W.-L.; Cisneros L.; Cohen C.; Colombo M.; Conway B.; Cooper C.; Craxi A.; Crespo J.; Croes E.; Cryer D.; Cupertino de Barros F.P.; Derbala M.; Dillon J.; Doss W.; Dou X.; Doyle J.; Duberg A.-S.; Dugan E.; Dunn R.; Dusheiko G.; El Khayat H.; El-Sayed M.H.; Eshraghian A.; Esmat G.; Esteban Mur R.; Ezzat S.; Falconer K.; Fassio E.; Ferrinho P.; Flamm S.; Flisiak R.; Foster G.; Fung J.; García-Samaniego J.; Gish R.G.; Gonçales F.; Halota W.; Hamoudi W.; Hassany M.; Hatzakis A.; Hay S.; Himatt S.; Hoepelman I.M.; Hsu Y.-C.; Hui Y.T.; Hunyady B.; Jacobson I.; Janjua N.; Janssen H.; Jarcuska P.; Kabagambe K.; Kanto T.; JIA-HORNG KAO ; Kaymakoglu S.; Kershenobich D.; Khamis F.; Kim D.J.; Kim D.Y.; Kondili L.A.; Kottilil S.; Kramvis A.; Kugelmas M.; Kurosaki M.; Lacombe K.; Lagging M.; Lao W.-C.; Lavanchy D.; Lazarus J.V.; Lee A.; Lee S.S.; Levy M.; Liakina V.; Lim Y.-S.; Liu S.; Maddrey W.; Malekzadeh R.; Marinho R.T.; Mathur P.; Maticic M.; Mendes Correa M.C.; Mera J.; Merat S.; Mogawer S.; Mohamed R.; Muellhaupt B.; Muljono D.; Mostafa I.; Nahum M.S.; Nawaz A.; Negro F.; Ninburg M.; Ning Q.; Ntiri- Reid B.; Nymadawa P.; Oevrehus A.; Ormeci N.; Orrego M.; Osman A.; Oyunsuren T.; Pan C.; Papaevangelou V.; Papatheodoridis G.; Popping S.; Prasad P.; Prithiviputh R.; Qureshi H.; Ramji A.; Razavi-Shearer K.; Reddy R.; Remak W.; Richter C.; Ridruejo E.; Robaeys G.; Roberts S.; Roberts L.; Roudot-Thoraval F.; Saab S.; Said S.; Salamat A.; Sanai F.; Sanchez-Avila J.F.; Schiff E.; Schinazi R.; Sebastiani G.; Seguin-Devaux C.; Shanmugam R.P.; Sharara A.; Shilton S.; Shouval D.; Sievert W.; Simonova M.; Sohrabpour A.A.; Sonderup M.; Soza A.; Wendy Spearman C.; Steinfurth N.; Sulkowski M.; Tan S.-S.; Tanaka J.; Tashi D.; Thein H.-H.; Thompson P.; Tolmane I.; Toy M.; Valantinas J.; Van de Vijver D.; Vélez-Möller P.; Vince A.; Waked I.; Wang S.; Wedemeyer H.; Wong V.; Xie Q.; Yamada S.; Yang H.-I.; Yesmembetov K.; Yilmaz Y.; Younossi Z.; Yu M.-L.; Yuen M.-F.; Yurdaydin C.; Yusuf A.; Zekry A.; Zeuzem S.; Polaris Observatory Collaborators | Journal of Viral Hepatitis | 19 | 18 | |
| 2019 | Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping | JIA-HORNG KAO ; Lin C.-Y.; Chuang W.-L.; Cheng Y.-Y.; Hu J.-Y.; Liang W.-K.; Friebe P.; Palmer S.; Huang C.-S. | Diagnostic Microbiology and Infectious Disease | 1 | 1 | |
| 2013 | Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study | Dai C.-Y.; Tseng T.-C.; Wong G.L.H.; Huang J-F.; Wong V.W.S.; CHUN-JEN LIU ; Yu M.-L.; Chuang W.-L.; JIA-HORNG KAO ; Yuen Chan H.L.; DING-SHINN CHEN | Journal of Antimicrobial Chemotherapy | 19 | 19 | |
| 2007 | Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan | Sullivan S.D.; Veenstra D.L.; PEI-JER CHEN ; Chang T.-T.; Chuang W.-L.; Tsai C.; Patel K. | Journal of Gastroenterology and Hepatology (Australia) | 24 | 22 | |
| 2019 | Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium | Huang C.-F.; Iio E.; Jun D.W.; Ogawa E.; Toyoda H.; Hsu Y.-C.; Haga H.; Iwane S.; Enomoto M.; Lee D.H.; Wong G.; CHEN-HUA LIU ; Tada T.; Chuang W.-L.; Cheung R.; Hayashi J.; Tseng C.-H.; Yasuda S.; Tran S.; Kam L.; Henry L.; Jeong J.Y.; Nomura H.; Park S.H.; Nakamuta M.; Huang J.-F.; Tai C.-M.; Lo G.-H.; Lee M.-H.; Yang H.-I.; JIA-HORNG KAO ; Tamori A.; Eguchi Y.; Ueno Y.; Furusyo N.; Tanaka Y.; Yu M.-L.; Nguyen M.H.; For the REAL-C Investigators | Hepatology International | 30 | 27 | |
| 2020 | Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply | Estes C.; Chan H.L.Y.; Chien R.N.; Chuang W.-L.; Fung J.; Goh G.B.-B.; Hu T.H.; Huang J.-F.; Jang B.K.; Jun D.W.; JIA-HORNG KAO ; Lee J.-W.; Lin H.-C.; Razavi-Shearer K.; Seto W.-K.; Wong G.L.H.; Wong V.W.S.; Razavi H. | Alimentary Pharmacology and Therapeutics | 1 | 0 | |
| 2018 | The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C | Younossi Z.M.; Stepanova M.; Henry L.; Han K.-H.; Ahn S.H.; Lim Y.-S.; Chuang W.-L.; JIA-HORNG KAO ; Kinh N.; Lai C.L.; Yuen M.-F.; Chan H.L.-Y.; Lai W. | Liver International | 16 | 11 |
